Result Updates On Three AIM Listed Stocks: CREO, ALT and AAU

Creo Medical Group PLC

AIM-listed Creo Medical Group Plc (CREO) is engaged in the development and commercialisation of less-invasive medical equipment with special emphasis on endoscopy. The group is headquartered in Chepstow, the UK and is a constituent of FTSE AIM 100 and FTSE AIM All-Share-Health care.

CREO-Financial highlights for H1 FY19

The company’s total sales were recorded at £40,104 during the period. However, related to direct sales, the company’s revenue was recorded at £7,699 in H1 FY19. The company’s gross profit stood at £4,617 in H1 FY19. The company’s other operating income was recorded at £75,000 in H1 FY19. The company made share-based payments of £510,000 in H1 FY19. The company’s administrative expenses surged to £5.0 million in H1 FY19 from £3.0 million in H1 FY18. The company’s operating loss stood at £9.4 million in H1 FY19 as against £5.2 million in H1 FY18. The company’s operating loss (underlying) was recorded at £7.2 million for the period as against £3.6 million in H1 FY18. The company’s loss per share was recorded at 6 pence per share in H1 FY19 as against 5 pence per share in H1 FY18.

The company’s net cash used for operations was recorded at £5.9 million in H1 FY19 as against £2.6 million in H1 FY18.  This surge in net cash can be attributed to increased investments in research and development during this period. The company issued new ordinary shares which resulted in net cash of £0.2 million generated in H1 FY19. The company had cash and cash equivalents of £38.7 million at 30 June 2019 as against £6.4 million at 30th June 2018. The company’s net assets were valued at £40.5 million at 30th June 2019 as against £7.3 million at 30th June 2018. The company’s financial performance was in line with management’s expectations. 

CREO-Share price performance

While writing (as on 04 October 2019, at 08:50 AM GMT), Creo Medical Group Plc shares were trading at GBX 151.04 per share; surged by 1.71 per cent as compared to the previous day closing price level. The company’s market capitalisation was around £180.08 million.

CREO shares have clocked a high of GBX 242 (as on 01 February 2019) and a low of GBX 128 (as on 03 September 2019) in the past year.

At the time of writing, the stock’s volume before the market close stood at 15,833. Stock’s average traded volume for 5 days was 49,473.20; 30 days- 43,554.50 and 90 days – 50,156.77.

The average traded volume for 5 days surged by 13.59 per cent as against 30 days average traded volume. At the time of writing, the shares of the company were trading above the 30-days and 60-days SMA.

In the past one month, CREO shares have delivered a positive return of 14.67 per cent. On a YTD (Year-to-Date) time interval, the stock plunged by approximately 25.38 per cent and was down by 19.07 per cent in the last three months.

Share’s RSI (Relative Strength Index) for the 30-days, 14-days and 9-days was recorded at 49.00, 60.80 and 63.18 respectively. Also, the stock’s 3-days RSI was recorded at 65.61.

Altitude Group PLC

Altitude Group Plc (ALT) is the leading provider of information and technology services, which provide insights regarding product promotions for print and clothing industries by enterprise-level technology integrated through a Software as a Service (“SaaS”) model. These services are customised solutions for all clients who look forward to expanding their business through increased sales and improved efficiency. These services are cloud-based and use client-server architecture. The company also organise promotional events such as product roadshows.

ALT-Financial highlights for H1 FY19

The company’s revenue grew by 43 per cent to £5.4 million in H1 FY19 as against £3.8 million in H1 FY18. The company’s gross profit surged by 78 per cent to £3.7 million in H1 FY19 as against £2.1 million in H1 FY18. The company’s adjusted operating profit stood at £0.3 million in H1 FY19 as against a loss of £0.3 million in H1 FY18. The company remains debt-free along with net cash of £3.5 million at 30th June 2019 as against £0.4 million at 31st December 2018. The company’s operations in the US are now self-funded and profitable. The company’s revenues in the United States increased many-fold to $2 million in the quarter ended 30th June 2019. The company’s technology gross margin surged to 82 per cent in H1 FY19 as against 80 per cent in H1 FY18. The company’s administrative expenses surged by £1.8 million to £4.6 million in H1 FY19 as against £2.8 million in H1 FY18. The company’s cash outflow from operations stood at £1.0 million in H1 FY19 as against £1.9 million in H1 FY18. The company had cash balances of £3.5 million at 30 June 2019 as against £0.4 million by the end of the financial year 2018. The company had changed its accounting reference date to 31st March.

ALT-Share price performance

While writing (as on 04 October 2019, at 08:59 AM GMT), Altitude Group Plc shares were trading at GBX 44.3 per share; plunged by 2.63 per cent as compared to the previous day closing price level. The company’s market capitalisation was around £31.23 million.

ALT shares have clocked a high of GBX 119 (as on 23 May 2019) and a low of GBX 43.17 (as on 03 October 2019) in the past year.

At the time of writing, the stock’s volume before the market close stood at 18,086. Stock’s average traded volume for 5 days was 667,105.00; 30 days- 525,202.80 and 90 days – 324,732.74. The company’s stock beta (5Y monthly) was 0.89, which makes it less volatile as against the benchmark index.

The average traded volume for 5 days surged by 27.02 per cent as against 30 days average traded volume. At the time of writing, the shares of the company were trading below the 30-days and 60-days SMA.

In the past 1 month, ALT shares have delivered a negative return of 52.60 per cent. Also, on a YTD (Year-to-Date) time interval, the stock plunged by approximately 37.24 per cent and was down by 57.67 per cent in the last three months.

Share’s RSI (Relative Strength Index) for the 30-days, 14-days and 9-days was recorded at 32.51, 32.55 and 34.93 respectively. Also, the stock’s 3-days RSI was recorded at 28.36.

Ariana Resources PLC

AIM-listed gold exploration and development company, Ariana Resources PLC (AAU) has entered a joint venture gold mining operation in Turkey, which has a low operating cost and high profitability. The objective of this Joint venture is to derive a production of 50,000 oz gold every year.

AAU-Financial highlights for H1 FY19

The company reaps its share of profit from the joint venture (Kiziltepe Mine), which was recorded at £3 million in the first half of financial year 2019. The company’s operating costs were in line with the company’s expectations and profit before taxation was recorded at £2.3 million for the period. The company’s gold production surged by 14 per cent to 13,734 oz Au in H1 FY19 as against 12,037oz Au in H1 FY18. The company looks forward to structured partnerships in future.

AAU-Share price performance

While writing (as on 04 October 2019, at 09:11 AM GMT), Ariana Resources PLC shares were trading at GBX 2.06 per share; plunged by 1.90 per cent as compared to the previous day closing price level. The company’s market capitalisation was around £22.20 million.

AAU shares have clocked a high of GBX 2.60 (as on 24 June 2019) and a low of GBX 1.11 (as on 12 October 2018) in the past year.

At the time of writing, the stock’s volume before the market close stood at 73,813. Stock’s average traded volume for 5 days was 2,315,893.40; 30 days- 1,470,538.83 and 90 days – 2,182,216.83. The company’s stock beta (5Y monthly) was 0.33, which makes it less volatile as against the benchmark index.

The average traded volume for 5 days surged by 57.49 per cent as against 30 days average traded volume. At the time of writing, the shares of the company were trading below the 30-days and 60-days SMA.

In the past 1 month, AAU shares have delivered a negative return of 8.70 per cent. On a YTD (Year-to-Date) time interval, the stock surged by approximately 37.70 per cent and was down by 13.40 per cent in the last three months.

Share’s RSI (Relative Strength Index) for the 30-days, 14-days and 9-days was recorded at 45.55, 35.83 and 26.83 respectively. Also, the stock’s 3-days RSI was recorded at 4.41.